- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04904848
Turkish Version of the "Children's Assessment of Participation With Hands Scale
Cultural Adaptation, Validity and Reliability of the Turkish Version of the "Children's Assessment of Participation With Hands (CAP-H)" Scale in Children With Physical Disabilities
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The CAP-H scale was used to evaluate children's hand participation and to examine the validity and reliability of the Turkish version. The original scale was developed by Chien et al. in Australia in 2015 to evaluate the difficulties experienced by children aged 2-12 years in using the hands in daily living activities that require hand participation. In the adaptation of the CAP-H to Turkish, the standard protocol of the WHO for the adaptation of the scales to different languages was applied:
- Translation of the scale into the target language (forward translation)
- Review of the scale translated into the target language by an expert panel of 2 pediatric rehabilitation physiotherapists, who can speak both languages.
- Translation of the scale from the target language to the original language (back translation)
- Testing the translated scale and discussing its conceptual integrity
- Final version of the adapted scale (final version)
For validity of CAP-H, Gross Motor Function Classification System and Manual Assesment Classification System scales used.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Konyaalti
-
Antalya, Konyaalti, Kalkun, 07070
- Akdeniz University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- voluntary participation in the study,
- having a physical disability report,
- the evaluated child in the age range of 2-12 years, and
- the respondent (child or parent) to be Turkish literate
Exclusion Criteria:
- Do not want to participate in the study
- Not completing surveys
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Children's Assessment of Participation with Hands (CAP-H)" scale
Tidsramme: 2 week
|
The original scale was developed by Chien et al. in 2015 to evaluate the difficulties experienced by children aged 2-12 years in using the hands in daily living activities that require hand participation.
The scale consists of 32 items in 4 sections: self-care participation (9 items), recreational participation (11 items), educational participation (8 items), and domestic life and community participation (9 items).
Each section has 4 sub-scores of difference, frequency, independence and desire to change sections, scored with Likert-type responses, and higher scores indicate higher hand participation.
The percentage score is obtained by dividing the total score by the number of items marked in the sub-scores of difference and change request.
In frequency and independence scoring, the score is obtained by dividing the total score by the number of items marked.
|
2 week
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Gross Motor Function Classification System
Tidsramme: 1 week
|
The (GMFCS), developed for children, is a classification system based on the child's self-initiated movements with an emphasis on sitting, displacement and mobility. Since the motor functions of children vary depending on age, functions for each age group are defined for each level, including children under 2 years old, between 2 and 4 years old, between 4 and 6 years old, and between 6 and 12 years old. While it was previously used for children under the age of 12 years, it can now be used for young people between the ages of 12 and 18 years in its expanded form. GMFCS levels according to age Level I: walks without restrictions Level II: Walks with restrictions Level III: Walks using hand-held mobility aids Level IV: Self-movement is restricted; can use motor mobility vehicle. Level V: Transported in a hand-pushed wheelchair |
1 week
|
|
Manual Assesment Classification System
Tidsramme: 1 week
|
The Manual Assesment Classification System (MACS) is used to classify children's ability to hold objects in daily activities. Turkish validity and reliability studies have been conducted. While MACS evaluates the participation of both hands together in activities, it cannot evaluate the hands separately. The classification is graded as follows: I - Holds objects easily and successfully. II- Can hold many objects, but the speed and / or quality of achievement is somewhat reduced. III- Holds objects with difficulty; help is needed in modifying and / or organizing activities. IV- Holds a selected limited number of objects easily arranged in adapted situations. V- Cannot hold objects and has severely limited ability to perform even a simple action. |
1 week
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Sebahat Yaprak Cetin, Assoc, Akdeniz University
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- 2019-192
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Studiedata/dokumenter
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kun barn
-
MedDay Pharmaceuticals SAEurofins OptimedAfsluttetSunde frivillige | Nedsat leverfunktion af moderat Child Pugh-kategoriFrankrig, Ungarn
-
RenJi HospitalAfsluttetBlodpladeantal/miltdiameterforhold | Child-Pugh klassificeringKina
-
Stanford UniversityNational Cancer Institute (NCI)AfsluttetTilbagevendende hepatocellulært karcinom | Child-Pugh klasse A | Child-Pugh klasse BForenede Stater, Japan
-
Ohio State University Comprehensive Cancer CenterVarian Medical SystemsAfsluttetChild-Pugh klasse A | Stadium IIIA Hepatocellulært karcinom | Stadium IIIB hepatocellulært karcinom | Stadium IIIC hepatocellulært karcinom | Stadium IVA Hepatocellulært karcinom | Stadium IVB Hepatocellulært karcinom | Child-Pugh klasse BForenede Stater
-
Centre Hospitalier Universitaire DijonAfsluttetChild-Pugh A Hepatocellulært karcinomFrankrig
-
MindRank AI LtdIkke rekrutterer endnuHepatic Impairment (Mild and Moderate, Child-Pugh Class A and B) | Leverinsufficiens (MeSH ID: D048550)Kina
-
CatalYm GmbHRekrutteringChild-Pugh A Hepatocellulært karcinom | Ikke-operabelt eller metastatisk hepatocellulært karcinom | Svigt af førstelinjebehandling, der omfattede et godkendt anti-PD-(L)1-kompoundItalien, Tyskland
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCAfsluttetAvanceret hepatocellulært karcinom hos voksne | Child-Pugh klasse A | Trin III hepatocellulært karcinom | Stadium IIIA Hepatocellulært karcinom | Stadium IIIB hepatocellulært karcinom | Stadium IIIC hepatocellulært karcinom | Trin IV hepatocellulært karcinom | Stadium IVA Hepatocellulært karcinom | Stadium...Forenede Stater
-
AstraZenecaAfsluttetMavekræft | Avancerede solide maligniteter | Solid tumor | Child-Pugh A til B7 avanceret hepatocellulært karcinom | EGFR og/eller ROS Mutant NSCLC | LungemetastasekarcinomKorea, Republikken
Kliniske forsøg med Survey evaluation
-
Children's Mercy Hospital Kansas CityAfsluttet
-
Henry Ford Health SystemUkendt
-
Instituto de Neurologia y Neurocirugia Hospital...AfsluttetParkinsons sygdomMexico
-
Assistance Publique Hopitaux De MarseilleUkendtLivskvalitet | Perifer ansigtslammelseFrankrig
-
Chinese University of Hong KongAfsluttet
-
University GhentRekrutteringNakke smerter | Hovedpine | Hovedpine lidelser | Cervikal smerteBelgien
-
Gazi UniversityRekrutteringKronisk hoftesmerter | HoftesygdomKalkun
-
Abramson Cancer Center at Penn MedicineConquer Cancer FoundationAfsluttetGastrointestinale kræft | LungekræftForenede Stater
-
Sumeyra DOLUOGLUAfsluttetSmerte | Angst | Forældre | Komplikation af kirurgisk indgrebKalkun
-
Gazi UniversityAfsluttetHovedpine | Hovedpine lidelser | Hovedpine, migræne | Hovedpine Kronisk | Hovedpine, spændinger | Hovedpine MuskuløsKalkun